Genetic Analysis AS reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was NOK 2.21 million compared to NOK 1.65 million a year ago. Revenue was NOK 4.77 million compared to NOK 2.31 million a year ago. Net loss was NOK 6.68 million compared to NOK 6.84 million a year ago. Basic loss per share from continuing operations was NOK 0.27 compared to NOK 0.27 a year ago. Diluted loss per share from continuing operations was NOK 0.27 compared to NOK 0.27 a year ago.
For the nine months, sales was NOK 7.69 million compared to NOK 3.97 million a year ago. Revenue was NOK 15.08 million compared to NOK 5.76 million a year ago. Net loss was NOK 20.47 million compared to NOK 21.92 million a year ago. Basic loss per share from continuing operations was NOK 0.82 compared to NOK 0.88 a year ago. Diluted loss per share from continuing operations was NOK 0.82 compared to NOK 0.88 a year ago.